Infinity Pharmaceuticals Inc., a Cambridge drug discovery and development company, said that Joshua D. Hamermesh has been appointed its vice president of business and corporate development.
Before joining Infinity, Hamermesh held the position of senior vice president, strategy and corporate development at Pervasis Therapeutics Inc.,Infinity Pharmaceuticals said.